ArticlePharmaceuticals (Basel, Switzerland)2023

Comparative Assessment and High-Throughput Drug-Combination Profiling of TEAD-Palmitoylation Inhibitors in Hippo Pathway Deficient Mesothelioma.

Lale Evsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.